These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18536559)

  • 1. Antibodies for molecular imaging of cancer.
    Wu AM; Olafsen T
    Cancer J; 2008; 14(3):191-7. PubMed ID: 18536559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered antibodies for molecular imaging of cancer.
    Wu AM
    Methods; 2014 Jan; 65(1):139-47. PubMed ID: 24091005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology.
    Knowles SM; Wu AM
    J Clin Oncol; 2012 Nov; 30(31):3884-92. PubMed ID: 22987087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update.
    Sharkey RM; Karacay H; McBride WJ; Rossi EA; Chang CH; Goldenberg DM
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5577s-5585s. PubMed ID: 17875792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper-64-immunoPET imaging: bench to bedside.
    Natarajan A
    Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):356-363. PubMed ID: 33045821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive progress in immunoPET--not just a coincidence.
    McCabe KE; Wu AM
    Cancer Biother Radiopharm; 2010 Jun; 25(3):253-61. PubMed ID: 20578830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications.
    Fu R; Carroll L; Yahioglu G; Aboagye EO; Miller PW
    ChemMedChem; 2018 Dec; 13(23):2466-2478. PubMed ID: 30246488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging role of immunoPET in receptor targeted cancer therapy.
    Marik J; Junutula JR
    Curr Drug Deliv; 2011 Jan; 8(1):70-8. PubMed ID: 21034420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear imaging probes: from bench to bedside.
    Wester HJ
    Clin Cancer Res; 2007 Jun; 13(12):3470-81. PubMed ID: 17575209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal antibodies for diagnosis and therapy in oncological patients].
    Boven E; Haisma HJ; Pinedo HM
    Ned Tijdschr Geneeskd; 1995 Dec; 139(49):2552-8. PubMed ID: 8657317
    [No Abstract]   [Full Text] [Related]  

  • 11. Immuno-PET for Clinical Theranostic Approaches.
    Bailly C; Cléry PF; Faivre-Chauvet A; Bourgeois M; Guérard F; Haddad F; Barbet J; Chérel M; Kraeber-Bodéré F; Carlier T; Bodet-Milin C
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-PET: a navigator in monoclonal antibody development and applications.
    van Dongen GA; Visser GW; Lub-de Hooge MN; de Vries EG; Perk LR
    Oncologist; 2007 Dec; 12(12):1379-89. PubMed ID: 18165614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ImmunoPET: harnessing antibodies for imaging immune cells.
    Wu AM; Pandit-Taskar N
    Mol Imaging Biol; 2022 Apr; 24(2):181-197. PubMed ID: 34550529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody positron emission tomography imaging in anticancer drug development.
    Lamberts LE; Williams SP; Terwisscha van Scheltinga AG; Lub-de Hooge MN; Schröder CP; Gietema JA; Brouwers AH; de Vries EG
    J Clin Oncol; 2015 May; 33(13):1491-504. PubMed ID: 25779566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1925-33. PubMed ID: 23242718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered affinity proteins for tumour-targeting applications.
    Friedman M; Ståhl S
    Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunoscintigraphy with monoclonal antibodies].
    Scheidhauer K; Landthaler M; Denecke H; Stefani FH; Schumacher U; Leinsinger G; Eiermann W; Moser E; Lissner J
    Digitale Bilddiagn; 1987 Sep; 7(3):134-40. PubMed ID: 3500011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging with antibodies and engineered fragments.
    Freise AC; Wu AM
    Mol Immunol; 2015 Oct; 67(2 Pt A):142-52. PubMed ID: 25934435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies and antimatter: the resurgence of immuno-PET.
    Wu AM
    J Nucl Med; 2009 Jan; 50(1):2-5. PubMed ID: 19091888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotargeting of tumors: state of the art and prospects in 2000].
    Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I
    Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.